INTRODUCTION
In 1996, Harman proposed the ' free radical theory of aging ' [1] , which implicated an increase in the steady-state levels of oxidatively damaged biomolecules due to reactive oxygen species including superoxide ( [2] ). (i) Life expectancy declines with an increase in the generation of O # − or H # O # , in many species [3, 4] and in organisms with low levels of SOD [5] and catalase [6] . (ii) Life expectancy of Drosophila can be extended by up to one-third in mutants overexpressing both SOD and catalase [7] . The overexpression of SOD and catalase in these flies ameliorated the age-related accumulation of molecular oxidative damage and increased their resistance to acute oxidative stress.
Recently it has been shown that artificial SOD\catalase mimics [8] are able to increase the life span of nematodes by up to 50 % [9] . These mimetics belong to a group called the manganese-salen complexes [Mn-Salens ; where H # Salen is N,Nh-bis(salicylidene)-ethylenediamine]. Their biological activity has been examined, in association with a pharmaceutical company (Eukarion, Bedford, MA, U.S.A.), and has been shown to protect cells from oxidative stress in a large number of disease models, including Alzheimer's disease [10] , Parkinson's disease [11] , stroke [12] , motor neuron disease [13] , multiple sclerosis [14] , excitotoxic neuronal
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peroxynitrite (ONOO − ). We have been examining the interaction of EUK-8 and EUK-134 with NO and ONOO − . We find that in the presence of a per-species (H # O # , ONOO − , peracetate and persulphate), the Mn-Salen complexes are oxidized to the corresponding oxo-species (oxoMn-Salen). OxoMn-Salens are potent oxidants, and we demonstrate that they can rapidly oxidize NO to NO # and also oxidize nitrite (NO # − to nitrate (NO # − Key words : neurodegenerative, nitrosative stress, oxidative stress, peroxynitrite, sepsis.
injury [15] and ischaemia\reperfusion in both heart and kidney tissue [16, 17] . The structure of Mn-Salen complexes is shown in Figure 1 . The mechanism for the dismutation of O # − involves the reduction of Mn(III) to Mn(II) by O # − , which is oxidized to O # (eqn 1). This Mn(II) is subsequently oxidized back to Mn(III) by another molecule of O # − , yielding H # O # (eqn 2). This mechanism is very similar to that of MnSOD [18] .
The mechanism by which the Mn-Salen acts as a catalase mimetic involves the oxidation of Mn-Salen to an oxomanganesesalen complex (oxoMn-Salen) by H # O # , releasing water (eqn 3). The oxoMn-Salen is then reduced by another molecule of H # O # to regenerate the Mn-Salen and generate water and O # (eqn 4).
OxoMn-Salen complexes are powerful oxidants and have a wide range of uses in inorganic\organic synthesis (for a review, see [19] ). In this role, oxoMn-Salens are generated from Mn-Salens using a number of atomic-oxygen-donating species, including H # O # , but normally employing iodosylbenzene or hypochlorite (OCl − ) [20] . Neutrophils contain the enzymes myeloperoxidase and eosinophil peroxidase, which catalyse the reaction of H # O # with Cl − to generate OCl − [21] . OCl − has been implicated as an Figure 1 The structure of Mn-Salens
In EUK-8, X is H ; in EUK-134, X is OCH 3 .
agent causing oxidative stress in a number of disease states and has been shown to damage endothelial cells [22] .
In addition to oxidative stress, cells also face nitrosative stresses from certain nitrogen oxides, in both age and disease. NO is a free radical that has a key role in both normal physiological processes and disease states (for a general review, see [23] ; for a review about NO and the brain, see [24] ). NO reacts with O # − [25] at a rate approaching the diffusion barrier, generating peroxynitrite (ONOO − ). ONOO − is also generated rapidly from the reaction of nitroxyl anion (NO − ) and O # . NO − is generated from NO, by mitochondria, by two distinct reductants : ferrocytochrome c [26] and ubiquinol [27] .
ONOO − has a half-life of approx. 1 s under physiological conditions, i.e. in the presence of CO # [28] . ONOO − oxidizes protein and non-protein thiols [29] and methionine [30] . ONOO − is also capable of nitrosylating (addition of NO) and nitrating (addition of NO # ) a large number of compounds, including amino acids ; the nitration of tyrosine by ONOO − occurs in itro and in i o and is now well understood [31] .
Increased levels of nitrotyrosine, a marker of steady-state ONOO − levels, have been observed in aging mammalian tissues, including the white matter of monkey brain [32] , rat cerebral cortex [33] , rat aorta [34] and human cerebrospinal fluid [35] . In addition, serum nitrate (the major product of ONOO − breakdown) has been shown to increase in human serum in an age-dependent manner [36] .
Nitrosative stress has also been implicated in a number of disease states in brain (for a review, see [37] ), which have benefitted from treatment with Mn-Salen, including Alzheimer's disease (for a review, see [38] ), Parkinson's disease [39] , stroke [40] , motor neuron disease [41] and multiple sclerosis [42] . With this in mind we have examined the chemistry of Mn-Salen with respect to NO and ONOO − .
EXPERIMENTAL Preparation of Mn-Salen
Mn-Salens are relatively easy to prepare and to purify. Manganese N,Nh-bis(salicylidene)ethylenediamine chloride (EUK-8) and manganese 3-methoxy-N,Nh-bis(salicylidene)ethylenediamine chloride (EUK-134) were prepared according to the procedure of Baker et al. [12] , based on that of Boucher and Farrell [43, 44] . The bis(salicylaldehyde)ethylenediamine-substituted ligands were prepared by the addition of 50 ml of 200 mM ethylenediamine to an equal volume of 400 mM of the substituted aldehyde (salicylaldehyde for EUK-8 and o-vanillin for EUK-134) in 100 % ethanol. The precipitate was filtered, washed with 100 % ethanol and air-dried. Solid Mn(II) acetate tetrahydrate was added to a stirred suspension of 30 mM ligand (in 95 % ethanol) to a final concentration of 30 mM and refluxed for 1 h. The dark-brown solutions were dried under a stream of air. The crude product, a brown solid, was washed with acetone, filtered and air-dried. These acetate complexes were converted into the corresponding chlorides through treatment of an aqueous solution (final concentration, 100 mM) of the Mn-Salen acetate, warmed to 50 mC, with 500 mM KCl. The suspension was cooled in an ice\water bath and then filtered ; the brown solid was washed with water and acetone. The concentrations of the Mn-Salen were determined from the absorption spectra in absolute ethanol, as in [43] .
Preparation of NO
NO solutions were prepared as described previously [26] , by the addition of 2 M H # SO % to solid NaNO # in a Kipps apparatus. The NO gas was passed through three NaOH (20 %) traps to remove NO # , dried by passage through solid NaOH and then through a solid-CO # trap. The gas was collected in water that had undergone four vacuum\N # deoxygenation cycles.
Measurement of O 2 and NO
NO concentration was measured using a World Precision Instruments (WPI) ISO-200 NO electrode connected to a WPI ISO-NO Mark I NO meter. The data were collected via a PowerLab\800 (ADInstruments) data-collection interface. The electrode was placed in a 1 ml thermostatically jacketed glass reaction chamber, which also housed a Clark-type O # electrode (Rank Bros, Bottisham, Cambs., U. K.). The NO electrode was calibrated by filling the reaction chamber with KI\H # SO % (0.1 M) and titrating with stock solutions of NO − # .
Optical spectroscopy
Spectra were recorded at room temperature using a HewlettPackard 8453 diode array spectrophotometer.
Measurement of NO
Nitrite was assayed using the Griess reaction, and nitrate was assayed either by the nitrate reductase method of Green et al. [45] or the V(III) method of Miranda et al. [46] . Samples or standards of 100 µl were added to 50 µl of 2% (w\v) sulphanilamide in 5 % (v\v) HCl and 50 µl of 0.1 % naphthylethylenediamine hydrochloride in a 96-well plate (Nunc, Roskilde, Denmark). The absorbance, after 30 min of incubation, was recorded at 540 nm, using a SpectromaxPlus absorbance spectrophotometer (Molecular Devices).
Preparation of ONOO −
ONOO − was prepared from amyl nitrite and H # O # using the method of Uppu and Pryor [47] . Amyl nitrite was washed three times and 26 ml was added to 100 ml of 2 M H # O # , 2 M NaOH and 2 mM diethylenetriaminepenta-acetic acid (DTPA). This solution was stirred vigorously for 3 h at 4 mC. The lower aqueous layer was removed from the organic phase using a separating funnel and washed three times with an equal volume of ice-cold hexane. To remove residual H # O # , activated MnO # was added gradually to the ONOO − . The solution was aliquoted into Eppendorf tubes and stored at 200 K. After thawing, the ONOO − solutions were centrifuged to pellet MnO # . The concentration of ONOO − was determined spectrophotometrically using an absorption coefficient of 1670 M −" at 302 nm, in 100 mM NaOH. Oxidation of NO by oxomanganese-salen complexes
Cell culture
Primary cortical astrocyte cultures were prepared from neonatal Wistar rats (1-2 days old) as described by Bolan4 os et al. [48] . Cell suspensions were plated at a density of 1i10& cells : cm −# in 80 cm# flasks and were cultured for 7 days in -valine-based minimal essential medium (MEM) supplemented with 10 % (v\v) fetal bovine serum and 2 mM -glutamine to minimize fibroblast growth. Cells were then cultured for another 7 days in -valinebased MEM. Cultures showed 90-95 % immunopositivity against glial fibrillary acidic protein. Astrocytes were then seeded at a density of 1i10& cells : cm −# in six-well culture dishes and used for experiments after 24 h.
Cells were treated with interferon-γ (IFN-γ ; 100 units : ml −" ) jlipopolysaccharide (LPS ; 1 µg : ml −" ) or EUK-8 or EUK-134 (50 µM) for 24 h in Phenol Red-free, serum-free MEM. In addition, some cells were treated with a combination of either EUK-8 or EUK-134 and IFN-γ\LPS for 24 h. Some wells were left untreated. At the end of incubation period, the cell culture medium was collected and the cells were trypsinized and pelleted. The cell culture medium was analysed for nitrite and nitrate. The cell pellets were resuspended in respiration buffer (134.2 mM NaCl, 20 mM glucose, 20 mM Hepes, 5.3 mM KCl, 4.1 mM NaHCO $ , 2 mM CaCl # , 0.43 mM KH # PO % and 0.33 mM Na # HPO % , pH 7.4). Cell viability was assessed by Trypan Blue exclusion at the end of each incubation and found to be unaffected by the treatments.
Reagents
Bovine liver catalase was obtained from Boehringer Mannheim, rat recombinant IFN-γ was obtained from Calbiochem, LPS (Escherichia coli 026 : Bb), fetal bovine serum, MEM and tissueculture plastics were purchased from Life Technologies, and other reagents were obtained from Sigma-Aldrich, who now also supply bis(salicylaldehyde)ethylenediamine. Figure 2 (top panel) shows the aqueous absorbance spectra of EUK-8 and oxoEUK-8 at neutral pH. Conversion of Mn-Salen into the oxo-species is accompanied by a change in the spectrum. Figure 2 (bottom panel) shows the effect of various atomicoxygen-donating compounds on the difference spectra of 50 µM EUK-8. Persulphate, peracetate, H # O # and ONOO − were all capable of acting as atomic oxygen donors to EUK-8 and EUK-134 and generating the same spectral species as OCl − . This strongly suggests that Mn-Salen may be able to act therapeutically in the detoxification of excessive ONOO − and OCl − . The reason that lower levels of oxoEUK-8 were generated in the presence of H # O # , compared with the other atomic-oxygendonating reagents, is due to the catalase-like activity of EUK-8. Although H # O # generates the oxo-species (eqn 3), it also consumes it (eqn 4). It was found that 1 mM H # O # was the optimal concentration to add to 50 µM EUK-8 to generate the greatest level of the oxo-species, within the measured time frame.
RESULTS

Oxidation of EUK-8 by peroxides and OCl −
Catalase mimicry of EUK-8
We examined the kinetics of EUK-8's catalase-mimetic mode of action at neutral pH and 37 mC. Although EUK-8 does have some catalase-like activity, as reported by Baker et al. [12] , it is very much less active than catalase under the same conditions ( Figure 3, top panel) . The second-order rate constant for EUK-8 was only approx. 8.3 M −" : s −" (Figure 3, bottom panel) and for EUK-134 was approx. 30 M −" : s −" , approximately twice the values determined at 25 mC by Baker et al. [12] . These values compare with the rate for mammalian catalase of 10( M −" : s −" under similar conditions. This difference in the rates of H # O # consumption by these mimetics and the enzyme present in i o raises the possibility that the catalase-like activity of Mn-Salen complexes may not be their major cytoprotective action.
Effect of EUK-134 and oxoEUK-134 on NO
We examined the stability of NO in the presence and absence of EUK-134, prior to and following the addition of H # O # , measuring both NO and O # polarographically ( Figure 4 , top panel). Initially, H # O # was added to the chamber to a final concentration of 200 µM and this was followed by an aliquot of NO (final concentration, 6 µM). The addition of NO caused a rapid rise in the NO signal, which was followed by a slow decay, as the NO [49] , with the major difference being that, unlike catalase, NO does not bind to the metal centre. Figure 4 suggests that NO is incapable of reacting with Mn-Salen, but can rapidly react with oxoMn-Salen. This would suggest that the oxoMn-Salen is acting in a similar way to the ferryl group of compound II of catalase, another atomic oxygen donor. This was tested by generating oxoEUK-134 from another important pathogenic oxidant, ONOO − , an oxidant with a short half-life in this buffering system (approx. 2 s). We examined whether ONOO − -treated EUK-134 could also react with NO. Figure 5 (top panel) demonstrates that oxoEUK-134, generated by the addition of ONOO − to EUK-134, is capable of oxidizing NO. Here, as in Figure 4 (top panel), it can be seen that NO decays slowly in buffer (first NO addition). Addition of ONOO − to EUK-134 has no effect on the NO trace ; the apparent oxygen generation appears to be due to the addition of ice-cold ONOO − to the buffer. A similar consumption of NO was observed using ONOO − and EUK-8.
The formation of oxoEUK-8 was investigated using optical spectroscopy, measured using the 440-800 nm wavepair ( Figure 5, bottom panel) . The lower traces show the ONOO − -induced formation and decay of oxoEUK-8 in the presence and absence of NO. The spontaneous decay rate of oxoEUK-8 was 0.036p0.0034 s −" (n l 5) and almost doubled in the presence of 8 µM NO to 0.067p0.0074 s −" (n l 5), indicating a second-order In similar experiments examining the decay of oxoEUK-134 (utilizing the 455-800 nm, wavepair) it was found that the decay rate was essentially identical with that of oxoEUK-8 at 0.036p0.0017 s −" (n l 5). The decay of oxoEUK-134 in the presence of 8 µM NO was approximately twice that of oxoEUK-8, at 0.1224p0.0087 s −" (n l 5). The average stoichiometry for the consumption of the oxoEUK-134 by NO was 0.67 : 1 (n l 5), This stoichiometry suggests that one molecule of NO is oxidized by one molecule of oxoMn-Salen. Figure 5 (bottom panel) shows that the rate of oxoEUK-8 formation by ONOO − occurs within a few seconds, during which time ONOO − itself decays away. Because of the short half-life of ONOO − it is difficult to estimate accurately the rate constant for the reaction of ONOO − and Mn-Salen. From a number of experiments of the type shown in Figure 5 (bottom panel) the second-order rate constant for the reaction of ONOO − and EUK-8 or EUK-134 was calculated to be between 5i10$ and 2i10% M −" : s −" .
Effect of Mn-Salen and oxoMn-Salen on NO 2 −
We wished to examine the products of the decay of NO in the presence of oxoMn-Salen, and therefore assayed the solutions for Oxidation of NO by oxomanganese-salen complexes both nitrite and nitrate using the Griess reaction and the nitrate reductase method of Green et al. [45] . Upon assaying the products of the decay of NO, the levels of NO # − \NO $ − were less than the amount of NO added. We therefore examined the effects of Mn-Salen and oxoMn-Salen on NO # − in buffer. Mn-Salen had no effect on NO # − concentrations when determined by the Griess assay. It was found that both oxoEUK-134 and oxoEUK-8 were capable of consuming NO # − . Figure 6 shows the effect of H # O # concentration on the measurement of 100 µM NO # − in the presence of 200 µM EUK-134 after 30 min of incubation. It can be seen that NO − # is consumed in the presence of oxoMn-Salen, but not Mn-Salen (i.e. see Figure 6 in the absence of H # O # ). Control experiments, in which 50 nM catalase was added at the end of the incubation period, showed that trace levels of H # O # were not interfering with the Greiss assay.
It was found that both Mn-Salens inhibited the reduction of NO $ − to NO # − [45] by nitrate reductase and interfered with the conversion by V(III) [46] at the concentrations present in these assays. Using chemiluminesence determination of NO # − \NO $ levels where Cd was used to convert NO $ − into NO # − we were able to conclude that oxoMn-Salen acts as an atomic oxygen donor to NO # − , generating NO $ − . Figure 4 . NO (6 nmol : ml − 1 ) was added and its slow decay was monitored. Following the decay of NO, EUK-134 was added, followed immediately by ONOO − at a final concentration of 500 µM. Some 10 s later (by which time the ONOO − would have decayed away) another aliquot of NO was added. Following the decay of this NO, a final aliquot of NO was added to the chamber. Bottom panel : shows the effect of 8 µM NO on the decay of oxoEUK-8, measured using the 440 minus 800 nm wavepair. In the lower traces, 500 µM ONOO − was added to 50 µM EUK-8 in 100 mM potassium phosphate/20 µM DTPA, pH 7.0. In the control trace (>) the oxoEUK-8 was allowed to spontaneously decay. In the other trace () NO was added to a final concentration of 8 µM, where indicated by the arrow. The concentration of oxoEUK-8 was measured using an absorption coefficient of 4000 M − 1 at ∆440-800 nm. The upper trace is the difference in oxoEUK-8, generated by subtracting the two lower traces. In this pair of traces the ratio of oxoEUK-8 consumption to NO added was approx. 1 : 1. The average stoichiometry was 0.84 : 1 (n l 5 for controls and NO addition experiments). The insert shows the average first-order decay rate of oxoEUK-8 (pS.D.) in controls (0.036p0.0034) and experiments where 8 µM NO (0.067p0.0074) was added (n l 5). The consumption of NO following the addition of EUK-8 reflected the steady-state level of H # O # in the media, resulting mainly from the autoxidation of glucose [50] . Addition of 50 nM catalase instead of EUK-8 also resulted in a fall in the level of NO generated by activated astrocytes (similar to that observed by Brown [49] ). Control experiments with cell media, in the presence and absence of cells, showed that these glucosecontaining buffers contained levels of H # O # in the low micromolar range. Figure 7 (top panel, middle trace) shows the generation of NO by LPS\IFN-γ-treated astrocytes that had previously been exposed to EUK-8 in their growth medium. These cells were also capable of generating NO, but the steady-state level of NO reached by these cells in the presence of arginine was only approx. 0.56 µM NO. Addition of EUK-8 to the external medium resulted in a fall in the NO steady state to approx. 0.16 µM, suggesting that the external medium had a lower steady-state level of H # O # . The initial rates of NO production following the addition of arginine were 0.36 nmol of NO : mg −" : min −" in the absence of EUK-8 and 0.15 nmol of NO : mg −" : min −" in EUK-8-treated cells. However, as the rate of decay of NO in aqueous medium is proportional to [NO]# [51] , it is difficult to estimate the rate of NO generation.
−
Figure 4 Effect of H 2 O 2 and EUK-134 on the decay of NO
Effect of Mn-Salen-treated astrocytes on NO generation and decay
EUK-8 to
We wished to establish whether the EUK-8-treated cells were generating less NO than the controls or if the treated cells consumed NO at a greater rate, the latter argument being supported indirectly by the data in Figures 4 and 5 . Astrocytes were incubated for 24 h in the presence and absence of 50 µM EUK-8, harvested, pelleted, re-suspended in respiration buffer and placed (1 mg:ml −" ) in to a reaction chamber containing a NO electrode. NO was added to a final concentration of 2.5 µM and the decay of NO was monitored. Figure 7 (bottom panel) shows typical NO decay traces observed in the presence and absence of astrocytes, with or without EUK-8. NO decayed slowly in the respiration buffer ; the arrow in Figure 7 (bottom panel) indicates the half-life of NO, which was approx. 75 s. NO decayed more quickly (half-life approx. 67 s) in the presence of untreated astrocytes, similar to the decay observed in mitochondria, liposomes and cells [52] . In the EUK-8-treated cells this half-life fell to only 32 s. This suggests that Mn-Salen, added to cell growth medium, remains associated with astrocytes following washing and is still capable of becoming oxidized to the corresponding oxo-species. We measured the decay of NO in the presence of cells grown for 24 h in the presence of both EUK-8 and EUK-134. The average half-life of 2.5 µM NO in 1 mg : ml −" control cells was 63p4.7 s, whereas in EUK-8-treated astrocytes this half-life fell to 34p4.9 s. In EUK-134-treated cells the rate of NO consumption was even higher, exhibiting a half-life of 9.1p2.9 s (n l 10 in all cases). This difference between the EUK-8-and EUK-134-treated cells, with respect to the decay of NO, can be explained by the greater reactivity towards NO of oxoEUK-134, compared with oxoEUK-8.
We can estimate the rate of decay of NO at each of the steadystate levels observed in Figure 7 (top panel) from the data shown in Figure 7 (bottom panel). The rate of NO decay in control astrocytes at 1.15 µM NO was approx. 0.6 nmol of NO : min −" , very similar to the rate in EUK-8-treated astrocytes at 0.56 µM NO, approx. 0.53 nmol of NO : min −" . In a steady state, influx must match efflux, and so it appears that the rate at which NO is produced by the astrocytes is not altered by the presence of Mn-Salen, but that the rate of decay of NO is increased by treatment with Mn-Salen.
Measurement of NO 2 − /NO 3 − in Mn-Salen-treated astrocytic media and buffer
To confirm that Mn-Salen was not affecting the generation of NO, we measured the levels of NO # − \NO $ − in astrocytic growth media incubated for 24 h in the presence or absence of EUK-8 or EUK-134 with or without LPS\IFN-γ, using nitrate reductase, and then measuring NO # − by the Griess assay. We found that the NO $ − levels were approx. 30 % less in Mn-Salen-treated cells compared with controls (results not shown). We found that even the low levels of Mn-Salen in the media were able to disrupt NO $ − reductase and that low levels of oxoMn-Salen disrupted the V(III)-based method. Neither of these methods could be used to determine the NO $ − in astrocytic media that had been treated with Mn-Salen. When the media from Mn-Salen-treated astrocytes were assayed for NO # − \NO $ − using the chemiluminescence method, it was found that the total NO # − \NO $ − levels were the Astrocytes were incubated for 24 h in the absence or presence of 50 µM EUK-8 harvested and placed (1 mg : ml − 1 total protein) into a reaction chamber containing a NO electrode. NO was added to a final concentration of 2.5 µM and the decay of NO was monitored. NO decayed slowly in the respiration buffer, the arrow (6) indicating a half-life for NO of approx. 75 s. NO in the presence of untreated astrocytes had a half-life approx. 67 s. X in the middle trace indicates the concentration of 1.15 µM NO. In EUK-8-treated cells this fell to only approx. 32 s ; X in the upper trace indicates the part of the trace where the concentration is 0.56 µM. The average half-life of 2.5 µM NO in the presence of 1 mg : ml − 1 cells was 63p4.7 s in control astrocytes, whereas in EUK-8-treated astrocytes this half-life fell to 34p4.9 s (P 0.0005, n l 10).
same as in the LPS\IFN-γ-treated astrocytes. This confirmed that Mn-Salen alters the decay, but not the formation rate, of NO in activated astrocytes. (Figure 2, bottom panel) . In both cases the Mn-Salen is oxidized to the corresponding oxo-species via eqns (5) and (6) . (Figures 4 and 5) . As oxoMn-Salens act as atomicoxygen donor compounds [19] and in view of the aqueous chemistry of NO, it is likely that oxoMn-Salens oxidize NO to NO # (eqn 7). The inhibition of O # formation of oxoMn-Salens by NO and the stoichiometry of the reaction with the oxo-species of 0.67-0.84 : 1 supports this view. The NO # generated can then rapidly react with NO, producing N # O $ (eqn 8), which following hydration gives HNO # (eqn 9 ; see Wink et al. [51] ). Given that NO # is generated during the normal process of NO autoxidation, and that it reacts rapidly with NO, in itro and in i o, it is unlikely that its generation by Mn-Salen from NO in disease states will prove deleterious.
DISCUSSION
In addition, it was found that oxoMn-Salen complexes could also oxidize NO # − to NO $ − . We found that NO − # was consumed at concentrations of H # O # typical of those that are found in biological tissues [53] . The mechanism for this consumption of NO # means that great care must be exercised when measuring NO # − \NO $ − in the presence of Mn-Salens and oxoMn-Salens. It has been shown that Mn-Salens are useful agents in the treatment of disease states associated with oxidative stress [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . We have demonstrated that Mn-Salen can be used to modulate the production of NO by activated astrocytes (Figure 7 , top panel). The steady-state level of NO generated by Mn-Salentreated astrocytes was some 2.5 times lower than in untreated cells. The difference in the steady-state levels of NO is due to the oxidation of NO by the Mn-Salen-treated astrocytes. The interference caused to the assays originally used to establish NO # − \NO $ − levels in the astrocytic media initially suggested that Mn-Salens were altering the rate at which the astrocytes were generating NO. Close examination of the rates at which NO decayed in the presence of astrocytes, with or without Mn-Salen, demonstrates that only the NO decay rate was altered by Mn-Salen.
Mn-Salens may prove to be therapeutic agents where NO overproduction is a factor in pathophysiology, catalysing the oxidation of NO by H # O # , ONOO − or OCl − . Many of the disease states that are associated with overproduction of NO have little effective treatment, e.g. sepsis. Sepsis can be most simply defined as a spectrum of clinical conditions caused by the immune response of a host to infection or trauma and characterized by systemic inflammation and coagulation [54] . It ranges from a systemic inflammatory response and organ dysfunction to multiple organ failure, and ultimately death for many patients. Antibiotic therapy and intensive physiological support continues to be the main approach to the management of patients with severe sepsis. Despite the development of numerous therapeutic agents, these drugs do little to improve patient outcome [55] . Mn-Salens might prove useful in treating sepsis, and rational drug design or compound screening will locate Mn-Salens with poor catalase activity but rapid oxidation to oxoMn-Salens, i.e. the reaction shown in eqn (3) is rapid, but that in eqn (4) is slow. This would result in a high level of oxoMn-Salen in the presence of oxidizing, inflammatory species (H # O # , OCl − and ONOO − ). The oxoMn-Salens generated could then clear the body of a sepsis patient of excessive NO. Now that we have elucidated the mechanisms by which MnSalens react with biological reactive nitrogen species, our data may help explain the actions of these compounds in the treatment of disease and in their ability to extend life spans.
